Back

Alcohol and Opioids Modulate Excitatory Inputs to the SCN

Purvines, W. W.; Vierkant, V. V. M.; Westbo, P.; Wang, X.; Jones, J.; Earnest, D.; Wang, J.

2026-05-04 neuroscience
10.64898/2026.04.30.721903 bioRxiv
Show abstract

BackgroundDisturbance of circadian rhythms is a hallmark of substance use disorders, with depressant drugs often causing soporific effects such as reduced sleep latency. The suprachiasmatic nucleus (SCN) of the hypothalamus is the central circadian pacemaker in mammals, regulating daily rhythms in physiology and behavior. However, the cellular mechanisms through which depressants alter SCN function remain poorly defined. MethodsWe used whole-cell patch clamp electrophysiology in acute brain slices to examine how alcohol and opioids modulate excitatory glutamatergic transmission onto SCN neurons. Ethanol effects were examined both acutely and following chronic exposure paradigms. Optogenetic stimulation was used to activate either RHT input or -opioid receptor-expressing (MOR) terminals, and MOR agonists were used to assess opioid-mediated effects on synaptic transmission. ResultsWe show that acute application of ethanol paradoxically enhances SCN firing rates. In contrast, chronic alcohol exposure reduces glutamatergic drive. We also found that activating MOR+ terminals produced bidirectional modulation of SCN firing and that MOR+ inputs formed functional glutamatergic synapses onto SCN neurons. Notably, this transmission could be suppressed by the MOR agonists DAMGO and fentanyl. ConclusionsTogether, these findings reveal that both alcohol and opioids modulate glutamatergic input to the SCN. This work establishes the SCN as a novel target of depressant substances and highlights glutamatergic transmission as a key point of vulnerability in circadian dysregulation associated with substance use.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Neuropharmacology
60 papers in training set
Top 0.1%
10.4%
2
Addiction Neuroscience
17 papers in training set
Top 0.1%
10.1%
3
eneuro
389 papers in training set
Top 0.6%
8.4%
4
Addiction Biology
47 papers in training set
Top 0.2%
8.4%
5
Neuropsychopharmacology
134 papers in training set
Top 0.6%
4.8%
6
Psychopharmacology
59 papers in training set
Top 0.2%
4.3%
7
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.1%
3.2%
8
Scientific Reports
3102 papers in training set
Top 41%
3.1%
50% of probability mass above
9
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
3.1%
10
Translational Psychiatry
219 papers in training set
Top 2%
2.7%
11
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.1%
2.4%
12
PLOS ONE
4510 papers in training set
Top 46%
2.4%
13
Biology of Sex Differences
29 papers in training set
Top 0.2%
1.9%
14
Drug and Alcohol Dependence
37 papers in training set
Top 0.4%
1.7%
15
Frontiers in Behavioral Neuroscience
46 papers in training set
Top 0.5%
1.7%
16
British Journal of Pharmacology
34 papers in training set
Top 0.2%
1.5%
17
Neuroscience
88 papers in training set
Top 2%
1.3%
18
Journal of Psychopharmacology
14 papers in training set
Top 0.3%
1.3%
19
Behavioral Neuroscience
25 papers in training set
Top 0.2%
1.2%
20
Alcohol
15 papers in training set
Top 0.2%
1.2%
21
Brain Sciences
52 papers in training set
Top 1%
1.1%
22
Biological Psychiatry Global Open Science
54 papers in training set
Top 1%
0.9%
23
European Journal of Neuroscience
168 papers in training set
Top 1.0%
0.9%
24
The Journal of Neuroscience
928 papers in training set
Top 7%
0.9%
25
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.9%
0.8%
26
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.9%
0.7%
27
Behavioural Brain Research
70 papers in training set
Top 1%
0.7%
28
Frontiers in Neuroscience
223 papers in training set
Top 8%
0.7%
29
Biological Psychiatry
119 papers in training set
Top 3%
0.7%
30
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.7%
0.6%